Juan Jaen
Founder at ARCUS BIOSCIENCES, INC.
Net worth: 29 M $ as of 2024-03-30
Juan Jaen active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ARCUS BIOSCIENCES, INC. | President | 2015-04-30 | - |
| Founder | 2014-12-31 | - | |
| Director/Board Member | 2015-03-31 | 2024-01-28 | |
R2M Pharma, Inc.
 R2M Pharma, Inc. BiotechnologyHealth Technology R2M Pharma, Inc. develops, discovers, and manufactures pharmaceutical products. The private company is based in San Francisco, CA. | Director/Board Member | - | - |
Bella Charitable Foundation
 Bella Charitable Foundation Investment Trusts/Mutual FundsMiscellaneous Bella Charitable Foundation operates as a grant making charity. The private company is based in Burlingame, CA. | Director/Board Member | 2015-05-31 | - |
Breakpoint Therapeutics GmbH
 Breakpoint Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Breakpoint Therapeutics GmbH engages in the discovery and development of anti-cancer drugs. It aims to advance to clinical development first-in-class oncology drugs that interfere with DNA repair and replication stress tolerance pathways. The company is headquartered in Hamburg, Germany. | Director/Board Member | - | - |
Hexagon Bio, Inc.
 Hexagon Bio, Inc. BiotechnologyHealth Technology Hexagon Bio, Inc. operates as a data-driven biotechnology company. It engages in mining of fungal genome data for drugs. The company was founded by Maureen E. Hillenmeyer, Brian T. Naughton, Colin James Bell Harvey and Yi Tang and is headquartered in Menlo Park, CA. | Director/Board Member | - | - |
Shasqi, Inc.
 Shasqi, Inc. Pharmaceuticals: MajorHealth Technology Shasqi, Inc. operates as a biopharmaceutical company. It develops novel chemistry to optimize the healing power of modern medicine. The company was founded by Jose M. Mejia Oneto and is headquartered in San Francisco, CA. | Director/Board Member | - | - |
Career history of Juan Jaen
Former positions of Juan Jaen
| Companies | Position | Start | End |
|---|---|---|---|
Flexus Biosciences, Inc.
 Flexus Biosciences, Inc. BiotechnologyHealth Technology Flexus Biosciences, Inc. provides cancer therapeutics through innovative apps. It engages in leveraging unexploited insights in immunology to discover Agents for Reversal of Tumor Immunosuppression. The company was founded by Terry J. Rosen and Juan C. Jaen in 2013 and is headquartered in San Carlos, CA. | Chief Tech/Sci/R&D Officer | 2013-09-30 | 2015-03-31 |
| Founder | 2013-09-30 | 2015-03-31 | |
| President | 2013-09-30 | 2015-03-31 | |
| RAPT THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2013-09-30 | 2015-03-31 |
| President | 2013-09-30 | 2015-03-31 | |
| CHEMOCENTRYX, INC. | Chief Tech/Sci/R&D Officer | 2006-12-31 | 2013-08-31 |
| Corporate Officer/Principal | 2006-12-31 | 2011-03-03 | |
| ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Juan Jaen
| University of Michigan | Doctorate Degree |
| Universidad Complutense de Madrid | Undergraduate Degree |
Statistics
International
| United States | 14 |
| United Kingdom | 2 |
| Spain | 2 |
Operational
| Director/Board Member | 7 |
| Corporate Officer/Principal | 5 |
| President | 4 |
Sectoral
| Health Technology | 13 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| RAPT THERAPEUTICS, INC. | Health Technology |
| ARCUS BIOSCIENCES, INC. | Health Technology |
| Private companies | 11 |
|---|---|
Warner-Lambert Co.
 Warner-Lambert Co. Pharmaceuticals: MajorHealth Technology Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ. | Health Technology |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA. | Health Technology |
Parke-Davis & Co. Ltd.
 Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The private company is based in St. Helier, UK. | Health Technology |
Flexus Biosciences, Inc.
Flexus Biosciences, Inc. BiotechnologyHealth Technology Flexus Biosciences, Inc. provides cancer therapeutics through innovative apps. It engages in leveraging unexploited insights in immunology to discover Agents for Reversal of Tumor Immunosuppression. The company was founded by Terry J. Rosen and Juan C. Jaen in 2013 and is headquartered in San Carlos, CA. | Health Technology |
Hexagon Bio, Inc.
Hexagon Bio, Inc. BiotechnologyHealth Technology Hexagon Bio, Inc. operates as a data-driven biotechnology company. It engages in mining of fungal genome data for drugs. The company was founded by Maureen E. Hillenmeyer, Brian T. Naughton, Colin James Bell Harvey and Yi Tang and is headquartered in Menlo Park, CA. | Health Technology |
PACT Pharma, Inc.
 PACT Pharma, Inc. Pharmaceuticals: MajorHealth Technology PACT Pharma, Inc. develops pharmaceutical products. It offers personalizes adoptive cell therapies with neoantigen-targeted T cells against cancer. The company is headquartered in South San Francisco, CA. | Health Technology |
R2M Pharma, Inc.
R2M Pharma, Inc. BiotechnologyHealth Technology R2M Pharma, Inc. develops, discovers, and manufactures pharmaceutical products. The private company is based in San Francisco, CA. | Health Technology |
Bella Charitable Foundation
Bella Charitable Foundation Investment Trusts/Mutual FundsMiscellaneous Bella Charitable Foundation operates as a grant making charity. The private company is based in Burlingame, CA. | Miscellaneous |
Breakpoint Therapeutics GmbH
Breakpoint Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Breakpoint Therapeutics GmbH engages in the discovery and development of anti-cancer drugs. It aims to advance to clinical development first-in-class oncology drugs that interfere with DNA repair and replication stress tolerance pathways. The company is headquartered in Hamburg, Germany. | Health Technology |
Shasqi, Inc.
Shasqi, Inc. Pharmaceuticals: MajorHealth Technology Shasqi, Inc. operates as a biopharmaceutical company. It develops novel chemistry to optimize the healing power of modern medicine. The company was founded by Jose M. Mejia Oneto and is headquartered in San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Juan Jaen
- Experience